306 related articles for article (PubMed ID: 31478742)
1. Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study.
Chireshe R; Naidoo K; Nyamakura R
Afr J Prim Health Care Fam Med; 2019 Aug; 11(1):e1-e8. PubMed ID: 31478742
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district, Zimbabwe.
Gonah L; Moodley I; Hlongwana K
Afr J Prim Health Care Fam Med; 2020 Aug; 12(1):e1-e6. PubMed ID: 32787407
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe.
Magodoro IM; Esterhuizen TM; Chivese T
BMC Res Notes; 2016 Aug; 9():379. PubMed ID: 27484005
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
PLoS One; 2016; 11(2):e0148100. PubMed ID: 26862763
[TBL] [Abstract][Full Text] [Related]
5. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services.
Divala OH; Amberbir A; Ismail Z; Beyene T; Garone D; Pfaff C; Singano V; Akello H; Joshua M; Nyirenda MJ; Matengeni A; Berman J; Mallewa J; Chinomba GS; Kayange N; Allain TJ; Chan AK; Sodhi SK; van Oosterhout JJ
BMC Public Health; 2016 Dec; 16(1):1243. PubMed ID: 27955664
[TBL] [Abstract][Full Text] [Related]
6. The association between a detectable HIV viral load and non-communicable diseases comorbidity in HIV positive adults on antiretroviral therapy in Western Cape, South Africa.
George S; McGrath N; Oni T
BMC Infect Dis; 2019 Apr; 19(1):348. PubMed ID: 31029087
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of selected non-communicable disease risk factors among HIV patients on anti-retroviral therapy in Bushbuckridge sub-district, Mpumalanga province.
Mathebula RL; Maimela E; Ntuli NS
BMC Public Health; 2020 Feb; 20(1):247. PubMed ID: 32070315
[TBL] [Abstract][Full Text] [Related]
8. The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.
Julius H; Basu D; Ricci E; Wing J; Basu JK; Pocaterra D; Bonfanti P
Curr HIV Res; 2011 Jun; 9(4):247-52. PubMed ID: 21631427
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study.
Agu CE; Uchendu IK; Nsonwu AC; Okwuosa CN; Achukwu PU
BMC Public Health; 2019 Aug; 19(1):1143. PubMed ID: 31429736
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of probable common mental disorders in a population with high prevalence of HIV in Zimbabwe.
Chibanda D; Cowan F; Gibson L; Weiss HA; Lund C
BMC Psychiatry; 2016 Feb; 16():55. PubMed ID: 26926690
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease risk in an urban African population: a cross-sectional analysis on the role of HIV and antiretroviral treatment.
Vos AG; Hoeve K; Barth RE; Peper J; Moorhouse M; Crowther NJ; Venter WDF; Grobbee DE; Bots ML; Klipstein-Grobusch K
Retrovirology; 2019 Dec; 16(1):37. PubMed ID: 31796103
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients.
Bergersen BM; Sandvik L; Dunlop O; Birkeland K; Bruun JN
Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):731-6. PubMed ID: 14610658
[TBL] [Abstract][Full Text] [Related]
14. Hypertension among HIV-infected adults receiving highly active antiretroviral therapy (HAART) in Malaysia.
Hejazi N; Huang MS; Lin KG; Choong LC
Glob J Health Sci; 2013 Dec; 6(2):58-71. PubMed ID: 24576366
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
PLoS One; 2016; 11(5):e0155560. PubMed ID: 27195956
[TBL] [Abstract][Full Text] [Related]
16. Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study.
Peck RN; Shedafa R; Kalluvya S; Downs JA; Todd J; Suthanthiran M; Fitzgerald DW; Kataraihya JB
BMC Med; 2014 Jul; 12():125. PubMed ID: 25070128
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and correlates of dyslipidemia in HIV positive and negative adults in Western Kenya: A cross-sectional study.
Tilahun H; Masyuko SJ; Mogaka JN; Temu T; Kinuthia J; Osoti AO; Nakanjako D; Farquhar C; Page ST
Medicine (Baltimore); 2021 Mar; 100(10):e24800. PubMed ID: 33725834
[TBL] [Abstract][Full Text] [Related]
18. The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trial.
Gupta SK; Parker RA; Robbins GK; Dubé MP
Nephrol Dial Transplant; 2005 Oct; 20(10):2237-42. PubMed ID: 16105869
[TBL] [Abstract][Full Text] [Related]
19. Body mass index and noninfectious comorbidity in HIV-positive patients commencing antiretroviral therapy in Zimbabwe.
Bleasel JM; Heron JE; Shamu T; Chimbetete C; Dahwa R; Gracey DM
HIV Med; 2020 Nov; 21(10):674-679. PubMed ID: 32892487
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
